Loading cancer entity…
Loading cancer entity…
Clinical trials
4,036 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (701)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04806659 | A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia | unknown | Phase 1 | 41 | Nanjing Sanhome Pharmaceutical, Co., Ltd.INDUSTRY | 1 | Mar 19, 2021 | clinicaltrials |
| NCT04692948 | TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia | unknown | N/A | 5 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Mar 8, 2021 |
| NCT04747002 | Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients. | unknown | Phase 2 | 100 | Osaka UniversityOTHER | 1 | Mar 3, 2021 | clinicaltrials |
| NCT04766840 | Donor-derived CAR-T Cells in the Treatment of AML Patients | unknown | Phase 1 | 9 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Feb 23, 2021 | clinicaltrials |
| NCT03662724 | Venetoclax Registry(VENreg) | unknown | — | 100 | Hannover Medical SchoolOTHER | 1 | Feb 16, 2021 | clinicaltrials |
| NCT03096496 | Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy | unknown | — | 161 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT04709731 | Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia(CarPAs) | unknown | Phase 2 | 50 | Associazione Italiana Pazienti Leucemia Mieloide CronicaOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT04708444 | Prognostic Value of CD318 in AML at Assiut University Hospital. | unknown | — | 100 | Shimaa Arafa IbrahimOTHER | 0 | Jan 22, 2021 | clinicaltrials |
| NCT03955848 | INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS(NKAML) | unknown | N/A | 80 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT03530085 | Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT | unknown | Phase 2 / Phase 3 | 60 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04254640 | Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML | unknown | Phase 2 | 34 | Sun Yat-sen UniversityOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03135054 | Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD | unknown | Phase 2 | 40 | The University of Hong KongOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT04000698 | Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias | unknown | Phase 3 | 25 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT02172365 | Allogeneic SCT for CML, TKI Failure After TKI Failure | unknown | — | 350 | University Health Network, TorontoOTHER | 1 | Nov 2, 2020 | clinicaltrials |
| NCT01064570 | AIDA 2000 Guidelines | unknown | Phase 2 | 600 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT03083054 | Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia | unknown | Phase 1 / Phase 2 | 5 | University of Campinas, BrazilOTHER | 1 | Oct 12, 2020 | clinicaltrials |
| NCT04578847 | A Study of REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib)(READIT) | unknown | Phase 2 | 100 | National Research Center for Hematology, RussiaNETWORK | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04221971 | NK Cell Infusion for Patients With Acute Myeloid Leukemia | unknown | Phase 1 | 10 | Peking University People's HospitalOTHER | 1 | Oct 1, 2020 | clinicaltrials |
| NCT04373395 | Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML) | unknown | N/A | 65 | Zhejiang UniversityOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT04454580 | Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy | unknown | — | 15 | Ospedale Maggiore Di TriesteOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT02381379 | Malaysia Stop Tyrosine Kinase Inhibitor Trial(MSIT) | unknown | Phase 3 | 118 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Sep 14, 2020 | clinicaltrials |
| NCT04541277 | Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy | unknown | Phase 2 | 55 | Chinese PLA General HospitalOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04240600 | Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital Stay(HEMVEF) | unknown | N/A | 74 | Hospital General de MexicoOTHER_GOV | 1 | Sep 3, 2020 | clinicaltrials |
| NCT04527666 | Anticoagulation in Gastroesophageal Varices and JAK2 Mutation | unknown | — | 40 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 27, 2020 | clinicaltrials |
| NCT04525768 | Gastroesophageal Varices in Cavernoma | unknown | — | 80 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 25, 2020 | clinicaltrials |
| NCT04517175 | Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics? | unknown | — | 300 | Maastricht UniversityOTHER | 0 | Aug 18, 2020 | clinicaltrials |
| NCT04209712 | Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease | unknown | Early Phase 1 | 6 | Shanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaINDUSTRY | 1 | Jul 29, 2020 | clinicaltrials |
| NCT04288739 | Immunophenotyping and Xist Gene in AML(Xist) | unknown | — | 65 | Assiut UniversityOTHER | 1 | Jul 9, 2020 | clinicaltrials |
| NCT04272957 | A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms | unknown | Phase 1 | 75 | Hutchison Medipharma LimitedINDUSTRY | 1 | Jun 16, 2020 | clinicaltrials |
| NCT04392310 | Outcomes of Acute Myeloid Leukemia Patients | unknown | — | 50 | Assiut UniversityOTHER | 0 | May 18, 2020 | clinicaltrials |
| NCT04369287 | Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia(Euro_IDH_AML) | unknown | — | 654 | Istituto Clinico HumanitasOTHER | 1 | May 13, 2020 | clinicaltrials |
| NCT03417427 | A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML | unknown | Phase 2 | 100 | Xuejie JiangOTHER | 1 | Apr 27, 2020 | clinicaltrials |
| NCT03600558 | Efficacy of FLAG Regimen for the Treatment of Patients With AML | unknown | — | 60 | Tianjin Medical University General HospitalOTHER | 1 | Apr 24, 2020 | clinicaltrials |
| NCT04351022 | CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia | unknown | Phase 1 / Phase 2 | 20 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Apr 24, 2020 | clinicaltrials |
| NCT03547258 | Italian Non-Interventional Study of FLT3 Mutated AML Patients(FLAM) | unknown | — | 800 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT04070807 | Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2(AVALON) | unknown | — | 70 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT04353479 | Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia | unknown | Phase 2 | 29 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Apr 20, 2020 | clinicaltrials |
| NCT02638428 | Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy | unknown | Phase 2 | 90 | Samsung Medical CenterOTHER | 1 | Mar 19, 2020 | clinicaltrials |
| NCT04312607 | Value of CD26 Positive Leukemic Stem Cell in Myeloproliferative Neoplasm | unknown | — | 80 | Safaa AA KhaledOTHER | 0 | Mar 18, 2020 | clinicaltrials |
| NCT04311060 | Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study. | unknown | — | 100 | Mexican Agrupation for Hematology StudyOTHER | 1 | Mar 17, 2020 | clinicaltrials |
| NCT02667093 | Samples From Leukemia Patients and Their Donors to Identify Specific Antigens | unknown | — | 50 | PersImmune, IncINDUSTRY | 1 | Mar 4, 2020 | clinicaltrials |
| NCT03755856 | Long-term Outcomes for Acute Myeloid Leukemia Patients(1621-QLG-LG) | unknown | — | 343 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 8 | Mar 4, 2020 | clinicaltrials |
| NCT01619761 | NK Cells in Cord Blood Transplantation | unknown | Phase 1 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT02059720 | Haplo-SCT vs ASCT With or Without Decitabine in AML CR1 | unknown | Phase 3 | 212 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT02156297 | Sorafenib to Treat FLT3-ITD AML | unknown | — | 100 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT02272478 | Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations(AML18) | unknown | Phase 2 / Phase 3 | 1,600 | Cardiff UniversityOTHER | 2 | Jan 23, 2020 | clinicaltrials |
| NCT02605460 | Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission | unknown | Phase 2 | 20 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranOTHER | 1 | Jan 14, 2020 | clinicaltrials |
| NCT03977103 | Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT | unknown | Phase 2 | 80 | University Of PerugiaOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT04215822 | PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia | unknown | — | 80 | Assiut UniversityOTHER | 0 | Jan 3, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Mar 19, 2021source: clinicaltrials